Dr. Mobolaji M. Opeola, MD

Dr. Opeola practices at Westover Hills Dermatology in San Antonio, Texas.

Dr. Opeola's NPI, 1578762563, was assigned on July 11, 2007. Dr. Opeola graduated from Rutgers Robert Wood Johnson Medical School in 2004. Dr. Opeola's Texas license number on file is M9555.

Dr. Opeola's primary practice is Westover Hills Dermatology, at 11212 State Hwy 151, San Antonio, TX 78251 in Bexar County. The practice phone is (830) 276-2600.

Dr. Opeola's primary practice is Westover Hills Dermatology in San Antonio, Texas. The medical group on file is Westover Hills Dermatology. Dmand AI also links Dr. Opeola to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Opeola practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Opeola's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Opeola is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Opeola's licenses on file in 2 states: Texas and California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Opeola treats.

CMS data shows 3,906 Medicare services from Dr. Opeola across 16 procedure codes in 2024, for 926 Medicare patients. Medicare paid $208,695 for them. Every service was in an office.

CMS counts 926 Medicare patients who saw Dr. Opeola in 2024. The largest group is 65 to 74, with 478 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Opeola's median patient age at 59, with 62% women.

In 2024, Dr. Opeola wrote 1,076 Medicare Part D claims for 365 patients. 91% of them were for generic drugs. CMS names the drug for 855 of them, across 20 drugs with 11 or more claims each, at $26,874 in total drug cost. In 2023, CMS named 767 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Opeola for performance year 2024, reported individually. Dr. Opeola accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 845 procedures of removal of skin lesions by Dr. Opeola, more than 92% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Opeola.

CMS Open Payments shows 1,670 general payments to Dr. Opeola from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 38% of the total. Pfizer Inc. paid the most, $31,016.

Dmand AI lists 3 awards for Dr. Opeola, most recently CMS Stage 1 EHR in 2013.

Dr. Opeola graduated from Rutgers Robert Wood Johnson Medical School in 2004. Dr. Opeola is a member of AAD and ASDS.

Dr. Opeola is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.